| abstract |
The present invention relates to compounds - antagonists of the melanin-concentrating hormone having the formula (I) where R, q, R and R have certain meanings, or pharmaceutically acceptable salts, enantiomers, diastereomers of such a compound, or mixtures thereof, useful in the treatment, prevention or reduction of severity Symptoms associated with obesity and obesity related diseases. |